Lafont A M, Chai Y C, Cornhill J F, Whitlow P L, Howe P H, Chisolm G M
Department of Cell Biology, Cleveland Clinic Foundation, Ohio 44195.
J Clin Invest. 1995 Mar;95(3):1018-25. doi: 10.1172/JCI117746.
The ability of alpha-tocopherol to reduce restenosis after angioplasty was tested in a rabbit model in which angioplasty was performed on established atherosclerotic lesions. Lesions induced by 4 wk of cholesterol feeding after focal desiccation of femoral arteries were balloon dilated. 3 wk after angioplasty, angiographically determined minimum luminal diameters were less in the untreated group (0.80 +/- 0.51 mm) than in the group treated with oral alpha-tocopherol beginning 19 d before angioplasty (1.38 +/- 0.29 mm; P < 0.01). The cross-sectional area of the intima-media was greater in the untreated group (1.18 +/- 0.48 mm2) than in the alpha-tocopherol group (0.62 +/- 0.25 mm2, P < 0.0001). These differences were not due to vasoconstriction or altered plasma cholesterol. Alpha-tocopherol thus reduced restenosis after angioplasty in this model. In rabbit vascular smooth muscle cells, oxidized low density lipoprotein stimulated DNA synthesis. Alpha-tocopherol treatment inhibited DNA synthesis stimulated by oxidized low density lipoprotein, but not by serum. The findings are consistent with the hypothesis that oxidized lipids can stimulate hyperplasia and that antioxidants may limit hyperplasia by inhibiting either the oxidation or the proliferative effects of oxidants on cells.
在一个兔模型中测试了α-生育酚减少血管成形术后再狭窄的能力,该模型对已形成的动脉粥样硬化病变进行血管成形术。在股动脉局灶性干燥后通过4周喂食胆固醇诱导病变,然后进行球囊扩张。血管成形术后3周,血管造影测定的最小管腔直径在未治疗组(0.80±0.51mm)中小于在血管成形术前19天开始口服α-生育酚治疗的组(1.38±0.29mm;P<0.01)。未治疗组的内膜-中膜横截面积(1.18±0.48mm²)大于α-生育酚组(0.62±0.25mm²,P<0.0001)。这些差异不是由于血管收缩或血浆胆固醇改变。因此,在该模型中α-生育酚减少了血管成形术后的再狭窄。在兔血管平滑肌细胞中,氧化型低密度脂蛋白刺激DNA合成。α-生育酚处理抑制了氧化型低密度脂蛋白刺激的DNA合成,但不抑制血清刺激的DNA合成。这些发现与以下假设一致,即氧化脂质可刺激增生,而抗氧化剂可能通过抑制氧化剂对细胞的氧化或增殖作用来限制增生。